• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[参与抗击新冠疫情的非临床工作人员中SARS-CoV-2 IgG血清阳性率]

[SARS-CoV-2 IgG seroprevalence in personnel of the extraclinical fight against the COVID-19 pandemic].

作者信息

Brune Bastian, Korth Johannes, Fessmann Kai, Stappert Daniel, Nohl André, Lembeck Thomas, Standl Fabian, Stang Andreas, Dittmer Ulf, Witzke Oliver, Herrmann Anke, Dudda Marcel

机构信息

Ärztliche Leitung Rettungsdienst, Feuerwehr Essen, Essen, Deutschland.

Klinik für Hand‑, Unfall- und Wiederherstellungschirurgie, Universitätsmedizin Essen, Universitätsklinikum Essen, Hufelandstr. 55, 45147 Essen, Deutschland.

出版信息

Notf Rett Med. 2021 Oct 12:1-9. doi: 10.1007/s10049-021-00948-z.

DOI:10.1007/s10049-021-00948-z
PMID:34658665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8507503/
Abstract

BACKGROUND AND OBJECTIVES

The SARS-CoV‑2 pandemic and the different manifestations of the coronavirus disease 2019 (COVID-19) are a major challenge for health systems worldwide. Medical personnel have a special role in containing the pandemic. The aim of the study was to investigate the SARS-CoV‑2 IgG antibody prevalence in extraclinical personnel depending on their operational area in the fight against the COVID-19 pandemic.

METHODS

On May 28 and 29, 2020, serum samples were taken from 732 of 1183 employees (61.9%) of the professional fire brigade and aid organizations in the city area and tested for SARS-CoV‑2 IgG antibodies. The employees were divided into four categories according to their type of participation. category 1: decentralized PCR sampling teams, category 2: rescue service, category 3: fire protection, category 4: situation center. Some employees participated in more than one operational area.

RESULTS

SARS-CoV‑2 IgG antibodies were detected in 8 of 732 serum samples. This corresponds to a prevalence of 1.1%. A previous COVID-19 infection was known in 3 employees. In order to make a separate assessment of the other employees possible and to diagnose unknown infections, a corrected collective of 729 employees with 6 SARS-CoV‑2 antibody detection was considered separately. The prevalence in the corrected collective is 0.82%. After subdividing the collective into areas of activity, the prevalence was low (1: 0.77%, 2: 0.9%, 3: 1.00%, 4: 1.58%).

CONCLUSIONS

The seroprevalence of SARS-CoV‑2 in the study collective is low at 1.1% and 0.82%, respectively. There is an increased seroprevalence in operational areas with a lower risk of virus exposure in comparison to operational areas with a higher risk.

摘要

背景与目的

严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)大流行以及2019冠状病毒病(COVID-19)的不同表现形式是全球卫生系统面临的重大挑战。医务人员在遏制疫情方面发挥着特殊作用。本研究的目的是根据临床外人员在抗击COVID-19疫情中的工作领域,调查其SARS-CoV-2 IgG抗体流行情况。

方法

2020年5月28日和29日,从市区专业消防队和救援组织的1183名员工中的732名(61.9%)采集血清样本,检测SARS-CoV-2 IgG抗体。员工根据参与类型分为四类。第1类:分散式PCR采样小组,第2类:救援服务,第3类:消防,第4类:情况中心。一些员工参与了多个工作领域。

结果

732份血清样本中有8份检测出SARS-CoV-2 IgG抗体。这相当于流行率为1.1%。已知3名员工曾感染COVID-19。为了能够对其他员工进行单独评估并诊断未知感染,对729名员工的校正样本进行单独考虑,其中有6例检测出SARS-CoV-2抗体。校正样本中的流行率为0.82%。将样本按活动领域细分后,流行率较低(第1类:0.77%,第2类:0.9%,第3类:1.00%,第4类:1.58%)。

结论

研究样本中SARS-CoV-2的血清流行率较低,分别为1.1%和0.82%。与病毒暴露风险较高的工作领域相比,病毒暴露风险较低的工作领域血清流行率有所增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8423/8507503/9ddf6f332d50/10049_2021_948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8423/8507503/919e4d727181/10049_2021_948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8423/8507503/9ddf6f332d50/10049_2021_948_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8423/8507503/919e4d727181/10049_2021_948_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8423/8507503/9ddf6f332d50/10049_2021_948_Fig2_HTML.jpg

相似文献

1
[SARS-CoV-2 IgG seroprevalence in personnel of the extraclinical fight against the COVID-19 pandemic].[参与抗击新冠疫情的非临床工作人员中SARS-CoV-2 IgG血清阳性率]
Notf Rett Med. 2021 Oct 12:1-9. doi: 10.1007/s10049-021-00948-z.
2
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
3
Seroprevalence of SARS-CoV2 Infections in Health Care Personnel in a Long-Term Care Institution After the First Wave of the Pandemic: A Cross-Sectional Study.大流行第一波后长期护理机构中医疗保健人员中 SARS-CoV2 感染的血清阳性率:一项横断面研究。
Workplace Health Saf. 2023 May;71(5):229-237. doi: 10.1177/21650799221135587. Epub 2023 Jan 27.
4
Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers.评估针对 COVID-19 的预防措施和 SARS-CoV-2 IgG 抗体血清阳性率在癌症门诊患者和医护人员中的纵向效果。
Wien Klin Wochenschr. 2021 Apr;133(7-8):359-363. doi: 10.1007/s00508-020-01807-6. Epub 2021 Jan 27.
5
SARS-COV-2 Infection and Specific Antibody Detection on Health Care Workers from a Military Hospital in Madrid, Spain.西班牙马德里一家军事医院医护人员中 SARS-CoV-2 感染和特异性抗体检测。
Curr Microbiol. 2021 Aug;78(8):2910-2915. doi: 10.1007/s00284-021-02541-6. Epub 2021 Jun 22.
6
Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees.德国医院员工中 SARS-CoV-2 抗体的半年纵向血清流行率和规则遵守情况。
Int J Environ Res Public Health. 2021 Oct 19;18(20):10972. doi: 10.3390/ijerph182010972.
7
Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.西班牙6000多名医护人员中新型冠状病毒2型抗体的血清阳性率
Int J Epidemiol. 2021 May 17;50(2):400-409. doi: 10.1093/ije/dyaa277.
8
COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study.COVID-19:热点医院?-德国二级保健医院网络中医院员工的 SARS-CoV-2 抗体血清阳性率:一项前瞻性监测研究的中期结果。
Int J Hyg Environ Health. 2021 Jun;235:113771. doi: 10.1016/j.ijheh.2021.113771. Epub 2021 May 20.
9
[SARS-CoV-2 antibodies in ICU and clinic staff : From Germany's region with the highest infection rate].[重症监护病房及临床医护人员体内的新型冠状病毒抗体:来自德国感染率最高地区的情况]
Med Klin Intensivmed Notfmed. 2020 Dec;115(Suppl 3):139-145. doi: 10.1007/s00063-020-00761-5. Epub 2020 Dec 3.
10
Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.退伍军人事务部医疗保健系统员工中严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染的血清阳性率表明,当在工作环境之外接触 SARS-CoV-2 时,感染的风险更高。
Infect Control Hosp Epidemiol. 2021 Apr;42(4):392-398. doi: 10.1017/ice.2020.1220. Epub 2020 Sep 23.

引用本文的文献

1
Seroprevalence of SARS-CoV-2 Antibodies in Employees of Three Hospitals of a Secondary Care Hospital Network in Germany and an Associated Fire Brigade: Results of a Repeated Cross-Sectional Surveillance Study Over 1 Year.德国一家二级保健医院网络的三家医院及其附属消防队员工中 SARS-CoV-2 抗体的血清阳性率:一项为期 1 年的重复横断面监测研究结果。
Int J Environ Res Public Health. 2022 Feb 19;19(4):2402. doi: 10.3390/ijerph19042402.

本文引用的文献

1
Persistence of IgG response to SARS-CoV-2.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的IgG反应的持续性。
Lancet Infect Dis. 2021 Feb;21(2):163-164. doi: 10.1016/S1473-3099(20)30943-9. Epub 2020 Dec 17.
2
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.德国一家三级护理中心医院工作人员中新型冠状病毒2抗体的血清流行率:一项序贯随访研究。
Int J Hyg Environ Health. 2021 Mar;232:113671. doi: 10.1016/j.ijheh.2020.113671. Epub 2020 Nov 30.
3
Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients.
新冠病毒肺炎患者中新冠病毒2型特异性抗体的持久性。
Int Immunopharmacol. 2021 Jan;90:107271. doi: 10.1016/j.intimp.2020.107271. Epub 2020 Dec 9.
4
[SARS-CoV-2 antibodies in ICU and clinic staff : From Germany's region with the highest infection rate].[重症监护病房及临床医护人员体内的新型冠状病毒抗体:来自德国感染率最高地区的情况]
Med Klin Intensivmed Notfmed. 2020 Dec;115(Suppl 3):139-145. doi: 10.1007/s00063-020-00761-5. Epub 2020 Dec 3.
5
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.人类感染 SARS-CoV-2 后三个月内中和抗体反应的纵向观察和下降。
Nat Microbiol. 2020 Dec;5(12):1598-1607. doi: 10.1038/s41564-020-00813-8. Epub 2020 Oct 26.
6
Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital.德国一家二级保健医院卫生保健工作者中 SARS-CoV-2 的前瞻性血清流行病学评估。
Int J Infect Dis. 2021 Jan;102:136-143. doi: 10.1016/j.ijid.2020.10.026. Epub 2020 Oct 16.
7
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.COVID-19 患者中针对 SARS-CoV-2 刺突蛋白受体结合域的人抗体反应的持久性和衰减。
Sci Immunol. 2020 Oct 8;5(52). doi: 10.1126/sciimmunol.abe0367.
8
Survival of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Virus on Human Skin: Importance of Hand Hygiene in Coronavirus Disease 2019 (COVID-19).严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和流感病毒在人皮肤上的存活情况:手部卫生在2019冠状病毒病(COVID-19)中的重要性
Clin Infect Dis. 2021 Dec 6;73(11):e4329-e4335. doi: 10.1093/cid/ciaa1517.
9
Evaluation of Abbott anti-SARS-CoV-2 CMIA IgG and Euroimmun ELISA IgG/IgA assays in a clinical lab.在临床实验室评估 Abbott 抗 SARS-CoV-2 CMIA IgG 和 Euroimmun ELISA IgG/IgA 检测试剂盒。
Clin Chim Acta. 2020 Nov;510:687-690. doi: 10.1016/j.cca.2020.09.002. Epub 2020 Sep 8.
10
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).评估三种免疫测定法(Euroimmun 和 Abbott 的两种自动化免疫测定法以及 NG Biotech 的一种快速侧向流动免疫测定法)用于诊断 COVID-19 的 SARS-CoV-2 血清学检测。
J Clin Virol. 2020 Aug;129:104511. doi: 10.1016/j.jcv.2020.104511. Epub 2020 Jun 15.